Today's Date: December 7, 2022
Loop Media, Inc. and ACTV8me Announce Strategic Partnership to Deploy Industry-First MarTech Solutions Across a Leading Digital   •   Cintas Again Named to Newsweek’s America’s Most Responsible Companies List   •   AHN West Penn Opens Butterfly Suite for Families Coping with Perinatal Loss   •   Because Market Named to Inc.'s 2022 Best in Business List   •   Government of Canada invests in MEDTEQ+ to fund groundbreaking technologies that will benefit Canada's seniors and their familie   •   University of Phoenix is Recognized by SHRM to Offer Professional Development Credits for the SHRM-CP or SHRM-SCP Credentials   •   Crowley and Wreaths Across America to Host Wreath Laying Ceremony to Honor Veteran Roberto Clemente 50 Years After His Passing   •   SpineThera Announces Results for SX600 from its SALIENT Phase 2 Sciatica Pain Clinical Trial Supporting the Potential for Best-I   •   Three Hightower Advisors Win Honors from InvestmentNews' Women to Watch Awards   •   2023 SPIE Startup Challenge Finalists to Showcase Innovative Photonics Technologies in Healthcare and Deep Tech   •   Impact Podcast with John Shegerian Features Hearst’s David Carey   •   Library and Archives Canada launches new Listen, Hear Our Voices funding cycle for 2023-2024, in support of First Nations, Inuit   •   Meijer Brightens Holiday for In-Store and Pickup Customers with Nearly $400,000 in Surprise Holiday Shopping Sprees   •   EQUITY ALERT: Rosen Law Firm Encourages Veru, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securiti   •   Ameresco Selected as 2022 S&P Global Platts Global Energy Awards Finalist in Two Categories   •   Commercial Litigation Attorney Aymen Khoury Joins Dorsey & Whitney in London   •   Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behal   •   Protecting more nature in partnership with Indigenous Peoples   •   Sara Romine Joins Lockton as U.S. General Counsel   •   Library and Archives Canada announces First Nations, Inuit and Métis Nation organizations receiving 2022-2023 funding fro
Bookmark and Share

HONEYWELL BEGINS PRODUCTION OF NEAR-ZERO GLOBAL-WARMING-POTENTIAL MEDICAL PROPELLANT

HONEYWELL BEGINS PRODUCTION OF NEAR-ZERO GLOBAL-WARMING-POTENTIAL MEDICAL PROPELLANT

PR Newswire

Honeywell Solstice® Air (HFO-1234ze(E) cGMP) to be used in next-generation respiratory inhalers from AstraZeneca

MORRIS PLAINS, N.J., Oct. 6, 2022 /PRNewswire/ -- Honeywell (Nasdaq: HON) today announced the opening of a plant in Baton Rouge, La., that is the company's first large-scale manufacturing site for Solstice® Air (HFO-1234ze(E) cGMP), a near-zero global-warming-potential (GWP) medical propellant for use in respiratory inhalers.

Solstice Air is a non-flammable, near-zero GWP, non-ozone-depleting, volatile organic compound (VOC)-exempt (per U.S. EPA and CARB) propellant in clinical development today for pressurized metered-dose inhalers (pMDIs). AstraZeneca (LON: AZN), a global leader in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), is working to incorporate Honeywell's Solstice Air technology, which is being evaluated for use as a medical propellant and has up to 99.9% less GWP than propellants currently used in inhaled respiratory medicines. AstraZeneca expects their triple-combination therapy Breztri Aerosphere (budesonide/ glycopyrronium/ formoterol fumarate) to be the first medicine to transition to the next-generation propellant, subject to regulatory approval, followed by the rest of their pMDI portfolio.

"AstraZeneca's commercial partnership with Honeywell is an excellent example of a true commitment to advancing healthcare innovation to improve outcomes both for patients and the planet," said Pablo Panella, senior vice president, Global Respiratory & Immunology, AstraZeneca. "Through close collaboration and extensive knowledge sharing between our two companies, we are committed to bringing the next generation of inhaled medicines with near-zero GWP propellant to patients. Honeywell's ability to escalate the production of Solstice Air at their new manufacturing site will help enable us to move quickly on this ambition once regulatory approval is achieved."

"Honeywell is dedicated to supporting our customers' environmental transformations with ready-now solutions," said Ken West, president of Honeywell Advanced Materials. "The opening of this plant in Baton Rouge is Honeywell's first site to produce medical grade propellant and our continued work with AstraZeneca offers a critical moment to highlight how Honeywell's Solstice technology plays an important role in helping the pharmaceutical industry meet its sustainability goals while supporting essential care for respiratory patients worldwide."

Honeywell has invested more than one billion dollars in research, development and new capacity for its Solstice technology, having anticipated the need for lower-GWP solutions to combat climate change more than a decade ago. The Solstice product line, which helps customers lower their greenhouse gas emissions and improve energy efficiency without sacrificing end-product performance, includes refrigerants for supermarkets, air conditioning for cars and trucks, blowing agents for insulation, propellants for personal and household care and solvents for cleaning solutions.

Using Honeywell Solstice technology has helped avoid the potential release of the equivalent of more than 295 million metric tons of carbon dioxide into the atmosphere so far, equal to the carbon emissions from nearly 688 million barrels of oil.

Honeywell is committed to achieving carbon neutrality in its operations and facilities by 2035 and recently announced a new set of commitments that further advance its sustainability goals, including committing to set a science-based target with the Science Based Targets initiative (SBTi) that will include scope 3 emissions and participation in the U.S. Department of Energy's Better Climate Challenge. The company also supports the Paris Climate Agreement. These efforts build on the company's track record of sharply reducing the greenhouse gas intensity of its operations and facilities as well as its decades-long history of innovation to help its customers meet their environmental and social goals. In 2021, approximately 60% of Honeywell's new product introduction research and development investment was directed toward products that improve environmental and social outcomes for customers.

For more information on Solstice Air (HFO-1234ze(E) cGMP), its applications, and impact, visit: https://sustainability.honeywell.com/us/en

For more information about sustainability at AstraZeneca, visit: https://www.astrazeneca.com/Sustainability.html

Honeywell (www.honeywell.com) delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

Media Contact:

Stephanie Agresti

stephanie.agresti@honeywell.com

973-289-0377

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/honeywell-begins-production-of-near-zero-global-warming-potential-medical-propellant-301642799.html

SOURCE Honeywell



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News